Advertisement
Screener

Assembly Biosciences, Inc. (ASMB) Weighted Average Number of Shares Outstanding, Basic and Diluted

2.8 / 5 stars · 68/120 Roast Me

Assembly Biosciences, Inc. Weighted Average Number of Shares Outstanding, Basic and Diluted

Assembly Biosciences, Inc. (ASMB) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 48.12 million shares for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-12.

Discontinued › Income Statement › Earnings Per Share

us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2022-05-12

  • Assembly Biosciences, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2022-03-31 was 48.12M shares, a 21.28% increase year-over-year.
  • Assembly Biosciences, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-12-31 was 44.95M shares, a 25.74% increase year-over-year.
  • Assembly Biosciences, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-09-30 was 45.57M shares, a 28.34% increase year-over-year.
  • Assembly Biosciences, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-03-31 was 39.68M shares, a 13.11% increase year-over-year.
  • Assembly Biosciences, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2021 was 43.28M shares, a 22.17% increase from fiscal 2020.
  • Assembly Biosciences, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 35.43M shares, a 34.92% increase from fiscal 2019.
  • Assembly Biosciences, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 26.26M shares, a 15.16% increase from fiscal 2018.
  • Assembly Biosciences, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 22.80M shares, a 28.46% increase from fiscal 2017.
Period endWeighted Average Number of Shares Outstanding, Basic and Diluted 3 monthWeighted Average Number of Shares Outstanding, Basic and Diluted 3 month as first filedWeighted Average Number of Shares Outstanding, Basic and Diluted 6 monthWeighted Average Number of Shares Outstanding, Basic and Diluted 6 month as first filedWeighted Average Number of Shares Outstanding, Basic and Diluted 9 monthWeighted Average Number of Shares Outstanding, Basic and Diluted 9 month as first filedWeighted Average Number of Shares Outstanding, Basic and Diluted 12 monthWeighted Average Number of Shares Outstanding, Basic and Diluted 12 month as first filed
2022-03-3148.12M shares
10-Q · filed 2022-05-12
46.54M shares
derived: average of 2 quarters · filed 2022-05-12
46.21M shares
derived: average of 3 quarters · filed 2022-05-12
2021-12-3144.95M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11
45.26M shares
derived: average of 2 quarters · filed 2022-03-11
43.28M shares
10-K · filed 2022-03-11
2021-09-3045.57M shares
10-Q · filed 2021-11-04
42.73M shares
10-Q · filed 2021-11-04
2021-03-3139.68M shares
10-Q · filed 2022-05-12
37.71M shares
derived: average of 2 quarters · filed 2022-05-12
36.98M shares
derived: average of 3 quarters · filed 2022-05-12
2020-12-3135.74M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11
35.63M shares
derived: average of 2 quarters · filed 2022-03-11
35.43M shares
10-K · filed 2022-03-11
2020-09-3035.51M shares
10-Q · filed 2021-11-04
35.32M shares
10-Q · filed 2021-11-04
2020-03-3135.08M shares
10-Q · filed 2021-05-06
31.41M shares
derived: average of 2 quarters · filed 2021-05-06
29.58M shares
derived: average of 3 quarters · filed 2021-05-06
28.62M shares
derived: average of 4 quarters · filed 2021-05-06
2019-12-3127.74M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25
26.83M shares
derived: average of 2 quarters · filed 2021-02-25
26.46M shares
derived: average of 3 quarters · filed 2021-02-25
26.26M shares
10-K · filed 2021-02-25
2019-09-3025.91M shares
10-Q · filed 2020-11-05
25.83M shares
derived: average of 2 quarters · filed 2020-11-05
25.77M shares
10-Q · filed 2020-11-05
25.71M shares
derived: average of 4 quarters · filed 2021-02-25
2019-06-3025.74M shares
10-Q · filed 2019-08-05
25.69M shares
10-Q · filed 2019-08-05
25.64M shares
derived: average of 3 quarters · filed 2021-02-25
25.45M shares
derived: average of 4 quarters · filed 2021-02-25
2019-03-3125.67M shares
10-Q · filed 2020-05-08
25.59M shares
derived: average of 2 quarters · filed 2021-02-25
25.35M shares
derived: average of 3 quarters · filed 2021-02-25
24.15M shares
derived: average of 4 quarters · filed 2021-02-25
2018-12-3125.50M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25
25.19M shares
derived: average of 2 quarters · filed 2021-02-25
23.64M shares
derived: average of 3 quarters · filed 2021-02-25
22.80M shares
10-K · filed 2021-02-25
2018-09-3024.88M shares
10-Q · filed 2019-11-07
22.71M shares
derived: average of 2 quarters · filed 2019-11-07
21.90M shares
10-Q · filed 2019-11-07
21.17M shares
derived: average of 4 quarters · filed 2020-03-04
2018-06-3020.54M shares
10-Q · filed 2019-08-05
20.39M shares
10-Q · filed 2019-08-05
19.93M shares
derived: average of 3 quarters · filed 2020-03-04
19.29M shares
derived: average of 4 quarters · filed 2020-03-04
2018-03-3120.23M shares
10-Q · filed 2019-05-09
19.63M shares
derived: average of 2 quarters · filed 2020-03-04
18.87M shares
derived: average of 3 quarters · filed 2020-03-04
18.49M shares
derived: average of 4 quarters · filed 2020-03-04
2017-12-3119.02M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-04
18.19M shares
derived: average of 2 quarters · filed 2020-03-04
17.91M shares
derived: average of 3 quarters · filed 2020-03-04
17.75M shares
10-K · filed 2020-03-04
2017-09-3017.37M shares
10-Q · filed 2018-11-08
17.36M shares
derived: average of 2 quarters · filed 2018-11-08
17.33M shares
10-Q · filed 2018-11-08
17.30M shares
derived: average of 4 quarters · filed 2019-02-28
2017-06-3017.34M shares
10-Q · filed 2018-08-08
17.31M shares
10-Q · filed 2018-08-08
17.28M shares
derived: average of 3 quarters · filed 2019-02-28
17.27M shares
derived: average of 4 quarters · filed 2019-02-28
2017-03-3117.27M shares
10-Q · filed 2018-05-07
17.25M shares
derived: average of 2 quarters · filed 2019-02-28
17.24M shares
derived: average of 3 quarters · filed 2019-02-28
17.24M shares
derived: average of 4 quarters · filed 2019-02-28
2016-12-3117.23M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28
17.23M shares
derived: average of 2 quarters · filed 2019-02-28
17.23M shares
derived: average of 3 quarters · filed 2019-02-28
17.23M shares
10-K · filed 2019-02-28
2016-09-3017.23M shares
10-Q · filed 2017-11-01
17.23M shares
derived: average of 2 quarters · filed 2017-11-01
17.23M shares
10-Q · filed 2017-11-01
17.23M shares
derived: average of 4 quarters · filed 2018-03-08
2016-06-3017.23M shares
10-Q · filed 2017-08-09
17.23M shares
10-Q · filed 2017-08-09
17.23M shares
derived: average of 3 quarters · filed 2018-03-08
17.22M shares
derived: average of 4 quarters · filed 2018-03-08
2016-03-3117.23M shares
10-Q · filed 2017-05-08
17.23M shares
derived: average of 2 quarters · filed 2018-03-08
17.22M shares
derived: average of 3 quarters · filed 2018-03-08
17.20M shares
derived: average of 4 quarters · filed 2018-03-08
2015-12-3117.24M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08
17.22M shares
derived: average of 2 quarters · filed 2018-03-08
17.19M shares
derived: average of 3 quarters · filed 2018-03-08
15.70M shares
10-K · filed 2018-03-08
2015-09-3017.21M shares
10-Q · filed 2016-11-09
17.16M shares
derived: average of 2 quarters · filed 2016-11-09
15.19M shares
10-Q · filed 2016-11-09
14.01M shares
derived: average of 4 quarters · filed 2017-03-02
2015-06-3017.12M shares
10-Q · filed 2016-08-09
14.16M shares
10-Q · filed 2016-08-09
12.95M shares
derived: average of 3 quarters · filed 2017-03-02
11.78M shares
derived: average of 4 quarters · filed 2017-03-02
2015-03-3111.18M shares
10-Q · filed 2016-05-10
10.86M shares
derived: average of 2 quarters · filed 2017-03-02
10.00M shares
derived: average of 3 quarters · filed 2017-03-02
8.68M shares
derived: average of 4 quarters · filed 2017-03-02
2014-12-3110.55M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-02
9.41M shares
derived: average of 2 quarters · filed 2017-03-02
7.84M shares
derived: average of 3 quarters · filed 2017-03-02
7.00M shares
10-K · filed 2017-03-02
2014-09-308.28M shares
10-Q · filed 2015-11-09
6.49M shares
derived: average of 2 quarters · filed 2015-11-09
5.81M shares
10-Q · filed 2015-11-09
5.39M shares
derived: average of 4 quarters · filed 2015-11-09
2014-06-304.70M shares
10-Q · filed 2015-08-13
4.56M shares
10-Q · filed 2015-08-13
4.43M shares
derived: average of 3 quarters · filed 2015-08-13
4.32M shares
derived: average of 4 quarters · filed 2015-08-13
2014-03-314.42M shares
10-Q · filed 2015-05-08
22.09M shares
10-Q · filed 2014-05-14
4.30M shares
derived: average of 2 quarters · filed 2015-05-08
4.19M shares
derived: average of 3 quarters · filed 2015-05-08
4.13M shares
derived: average of 4 quarters · filed 2015-05-08
2013-12-314.17M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16
4.08M shares
derived: average of 2 quarters · filed 2015-03-16
4.03M shares
derived: average of 3 quarters · filed 2015-03-16
3.88M shares
10-K · filed 2015-03-16
19.39M shares
10-K · filed 2014-03-31
2013-09-303.98M shares
10-Q · filed 2014-11-17
19.89M shares
10-Q · filed 2013-11-12
3.96M shares
derived: average of 2 quarters · filed 2014-11-17
3.78M shares
10-Q · filed 2014-11-17
18.90M shares
10-Q · filed 2013-11-12
9.48M shares
derived: average of 4 quarters · filed 2014-11-17
2013-06-303.94M shares
10-Q · filed 2014-08-14
19.72M shares
10-Q · filed 2013-08-09
3.68M shares
10-Q · filed 2014-08-14
18.40M shares
10-Q · filed 2013-08-09
11.31M shares
derived: average of 3 quarters · filed 2014-08-14
11.72M shares
derived: average of 4 quarters · filed 2014-08-14
2013-03-3117.06M shares
10-Q · filed 2014-05-14
14.99M shares
derived: average of 2 quarters · filed 2014-05-14
14.31M shares
derived: average of 3 quarters · filed 2014-05-14
13.89M shares
derived: average of 4 quarters · filed 2014-05-14
2012-12-3112.93M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31
12.93M shares
derived: average of 2 quarters · filed 2014-03-31
12.83M shares
derived: average of 3 quarters · filed 2014-03-31
12.73M shares
10-K · filed 2014-03-31
2012-09-3012.93M shares
10-Q · filed 2013-11-12
12.78M shares
derived: average of 2 quarters · filed 2013-11-12
12.66M shares
10-Q · filed 2013-11-12
12.60M shares
derived: average of 4 quarters · filed 2013-11-12
2012-06-3012.63M shares
10-Q · filed 2013-08-09
12.52M shares
10-Q · filed 2013-08-09
12.49M shares
derived: average of 3 quarters · filed 2013-08-09
12.27M shares
derived: average of 4 quarters · filed 2013-08-09
2012-03-3112.41M shares
10-Q · filed 2013-05-10
12.42M shares
derived: average of 2 quarters · filed 2013-05-10
12.15M shares
derived: average of 3 quarters · filed 2013-05-10
10.91M shares
derived: average of 4 quarters · filed 2013-05-10
2011-12-3112.44M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18
12.03M shares
derived: average of 2 quarters · filed 2013-03-18
10.41M shares
derived: average of 3 quarters · filed 2013-03-18
9.61M shares
10-K · filed 2013-03-18
2011-09-3011.62M shares
10-Q · filed 2012-11-13
9.40M shares
derived: average of 2 quarters · filed 2012-11-13
8.67M shares
10-Q · filed 2012-11-13
2011-06-307.18M shares
10-Q · filed 2012-08-09
7.18M shares
10-Q · filed 2012-08-09
2010-12-31619.92K shares
10-K · filed 2013-03-18

Similar stocks

Stock NameCountryMarket CapPE Ratio
Ovid Therapeutics Inc. (OVID)United States$0.487B-14.41
CAPRICOR THERAPEUTICS, INC. (CAPR)United States$0.499B-10.81
MapLight Therapeutics, Inc. (MPLT)United States$0.459B-7.10
PUMA BIOTECHNOLOGY, INC. (PBYI)United States$0.507B15.53
ARVINAS, INC. (ARVN)United States$0.510B58.38
Evolus, Inc. (EOLS)United States$0.519B-13.32
Quoin Pharmaceuticals Ltd. (QNRX)$0.443B-17.85
CYPHERPUNK TECHNOLOGIES INC. (CYPH)United States$0.438B-75.63
CRESCENT BIOPHARMA, INC. (CBIO)United States$0.529B-5.20
PROTHENA CORP PUBLIC LTD CO (PRTA)Ireland$0.428B-11.53